*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
TITLE: Biomanufacturing of Stem Cells
SPEAKER: Todd McDevitt
ABSTRACT:
The McDevitt Laboratory for the Engineering of Stem Cell Technologies is focused on the development and application of engineering principles to translate the potential of stem cells into viable regenerative therapies and in vitro diagnostics. Biomaterials-based approaches are used to engineer the microenvironment of stem cells in order to improve the efficiency and homogeneity of directed stem cell differentiation strategies.
In addition, the McDevitt laboratory’s research focuses on development of novel regenerative molecular therapies from natural biomaterials produced by stem cells. The combination of directed stem cell differentiation and development of stem cell-derived biomaterials is expected to yield fresh insights into stem cell biology, facilitate new regenerative therapies and create novel cell diagnostic platforms. The McDevitt laboratory research is supported by funding from the National Institutes of Health, National Science Foundation, American Heart Association and the Georgia Research Alliance, among others.
McDevitt was named the 2010 Society for Biomaterials Young Investigator from the Society of Biomaterials. He was appointed as a Petit Faculty Fellow in the Institute for Bioengineering and Bioscience in September 2009 and named the Director of the new Stem Cell Engineering Center at Georgia Tech, which launched in 2010. It is the first center of its kind in the United States will bring together expertise from different engineering disciplines to address key technical challenges that currently limit the translation of stem cells and to innovate new technologies that will enhance basic stem cell research.
